Xenon Pharmaceuticals Inc share price logo

Xenon Pharmaceuticals Inc Share Price

NASDAQ: XENE

Mid Cap

$36.68

+1.02

(+2.86%)

as on

Xenon Pharmaceuticals Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $35.99
    $37.95
    downward going graph

    1.88%

    Downside

    3.46%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $26.74
    $46
    downward going graph

    27.10%

    Downside

    25.41%

    Upside

    downward going graph

Xenon Pharmaceuticals Inc share price movements today

Previous Close
$35.66
Open
$36.06
Volume
855.3K
Day's Low - High
$35.99 - $37.95
52 Week Low - High
$26.74 - $46

Xenon Pharmaceuticals Inc Historical Returns

1 Month Return
-5.71 %
3 Month Return
+ 11.79 %
1 Year Return
-11.05 %
3 Year Return
-4.42 %
5 Year Return
+ 211.71 %

Xenon Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Xenon Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.7B

EPS (TTM)

-4.2949

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-18.61

Industry PE ratio

10.127857142857144

P/B Ratio

0

PEG Ratio

-0.06

EBITDA

-315.5M

Revenue (TTM)

7.5M

Profit Margin

0.00%

Return On Equity TTM

141433900.00%

Xenon Pharmaceuticals Inc Stock Valuation

Track how Xenon Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Xenon Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 18, 2025

Today (-18.61x)

September 18, 2025

Industry (10.13x)

September 18, 2025

Highest (0.00x)

September 18, 2025

LowHigh

Today’s Price to Earnings Ratio: -18.61x

Xenon Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xenon Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$2.7B211.71%-18.610.00%
BUY$60.5B248.74%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$99.3B45.88%27.5631.86%
BUY$60.9B5.45%14.4931.37%

Stock Returns calculator for Xenon Pharmaceuticals Inc Stock including INR - Dollar returns

The Xenon Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xenon Pharmaceuticals Inc investment value today

Current value as on today

₹96,092

Returns

₹3,908

(-3.91%)

Returns from Xenon Pharmaceuticals Inc Stock

₹8,506 (-8.51%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Xenon Pharmaceuticals Inc Stock

Based on 24 analysts

BUY

95.83%

Buy

4.17%

Hold

0.00%

Sell

Based on 24 analysts, 95.83% of analysts recommend a 'BUY' rating for Xenon Pharmaceuticals Inc. Average target price of $54.95

Xenon Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Xenon Pharmaceuticals Inc.

What analysts predicted

33.25%UPSIDE

Target Price

$54.95

Current Price

$36.68

Analyzed by

24 Analysts

Target

$54.95

Xenon Pharmaceuticals Inc target price $54.95, a slight upside of 33.25% compared to current price of $36.68. According to 24 analysts rating.

Xenon Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Xenon Pharmaceuticals Inc Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:11% versus previous 30 day period

Xenon Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
5
-
-
-
2
7
-
Gross Profit
0
0
-1
4
0
0
0
1
7
0
Operating Income
-49
-55
-55
-53
-59
-69
-73
-77
-72
-94
EBITDA
-48
-55
-53
-52
-58
-68
-73
-76
-72
-93
Interest Expense
7
-
-
7
-
-
-
-
-
-
Depreciation
0
0
1
0
0
0
0
0
0
0
Income Before Tax
-41
-47
-48
-44
-47
-58
-63
-69
-64
-85
Income Tax Expense
0
0
0
0
0
0
0
-3
0
0
Net Income
-41
-47
-48
-44
-47
-57
-62
-65
-65
-84
Net Profit Margin
0.00%
0.00%
0.00%
-831.65%
0.00%
0.00%
0.00%
-2610.69%
-867.29%
0.00%

Xenon Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
15
1
0
-
6
32
18
9
-
-
Gross Profit
15
0
-25
-6
-32
32
18
9
-167
-2
Operating Income
-9
-24
-32
-38
-42
-31
-78
-129
-214
-279
EBITDA
-8
-23
-30
-32
-39
-30
-78
-127
-210
-235
Interest Expense
-
-
-
1
1
0
1
5
-
-
Depreciation
-
-
0
0
0
0
0
1
3
2
Income Before Tax
-15
-22
-30
-34
-41
-29
-78
-125
-182
-238
Income Tax Expense
-1
-1
-1
4
0
0
0
0
0
-4
Net Income
-15
-22
-30
-34
-41
-28
-78
-125
-182
-234
Net Profit Margin
-101.12%
-1275.49%
-9872.67%
0.00%
-609.09%
-89.65%
-427.85%
-1328.95%
0.00%
0.00%

Xenon Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-47
-48
-44
-47
-57
-62
-65
-65
-84
Operating Cash Flow
-33
-42
-33
-43
-32
-51
-54
-61
-64
Investing Cash Flow
27
48
-239
-46
110
1
98
34
82
Financing Cash Flow
-
29
320
-
-
-
12
1
0
Change in Cash
-4
35
49
-89
77
-49
55
-26
18

Xenon Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-22
-30
-34
-41
-28
-78
-125
-182
-234
Operating Cash Flow
-19
-28
-34
-4
-48
-69
-98
-145
-181
Investing Cash Flow
-47
24
-28
-66
-16
-246
-296
-117
165
Financing Cash Flow
23
7
111
27
85
447
278
353
12
Change in Cash
-41
3
47
-42
20
130
-118
91
-5

Global Institutional Holdings in Xenon Pharmaceuticals Inc

Funds
Holdings
FMR Inc
10.8%
venBio Select Advisor LLC
7.48%
Driehaus Capital Management LLC
5.97%
Wellington Management Company LLP
4.94%
HHG PLC
4.33%

Insights on Xenon Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.51M → 7.5M (in $), with an average increase of 66.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 76.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 113.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -65.04M → -84.70M (in $), with an average decrease of 30.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, XENE stock has moved down by -3.0%

About Xenon Pharmaceuticals Inc

xenon® (nasdaq: xene) is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as extreme genetics. our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits, or phenotypes. we apply our expertise to predict which phenotypes are caused by single-gene defects. by identifying and characterizing the single-gene defects responsible for such severe phenotypes, we gain valuable insights into their function in human biology and their potential as drug targets. given that these targets are often involved in diseases beyond the rare genetic disorders in which they are first identified, we are developing proprietary product candidates to treat both orphan as well as more prevalent diseases.
OrganisationXenon Pharmaceuticals Inc
Headquarters200-3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8
IndustryHealth Technology
CEOMr. Ian C. Mortimer C.M.A., CPA, M.B.A.
E-voting on sharesClick here to vote

Key Management of Xenon Pharmaceuticals Inc

Name

Title

Mr. Darren S. Cline M.B.A.

Chief Commercial Officer and Member of Executive Team

Mr. Ian C. Mortimer C.M.A., CPA, M.B.A.

Interim CFO, President, CEO, Principal Financial Officer, Principal Accounting Officer & Director

Ms. Andrea DiFabio J.D.

Chief Legal Officer & Corporate Secretary

Dr. Christopher John Kenney M.D.

Chief Medical Officer

Dr. Matthew D. Ronsheim Ph.D.

Chief Operating Officer

Ms. Shelley McClCoskey B.A.

Executive Vice President of Human Resources

Dr. Robin P. Sherrington Ph.D.

Executive Vice President of Strategy & Innovation

Dr. James R. Empfield Ph.D.

Executive Vice President of Drug Discovery

FAQs

What is Xenon Pharmaceuticals Inc share price today?

Xenon Pharmaceuticals Inc share price today is $36.68 as on at the close of the market. Xenon Pharmaceuticals Inc share today touched a day high of $37.95 and a low of $35.99.

What is the 52 week high and 52 week low for Xenon Pharmaceuticals Inc share?

Xenon Pharmaceuticals Inc share touched a 52 week high of $46 on and a 52 week low of $26.74 on . Xenon Pharmaceuticals Inc stock price today i.e. is closed at $36.68,which is 20.26% down from its 52 week high and 37.17% up from its 52 week low.

What is Xenon Pharmaceuticals Inc's market capitalisation today?

Xenon Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Xenon Pharmaceuticals Inc Stock (XENE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Xenon Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xenon Pharmaceuticals Inc Shares that will get you 0.0409 shares as per Xenon Pharmaceuticals Inc share price of $36.68 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Xenon Pharmaceuticals Inc Stock (XENE) from India?

Indian investors can start investing in Xenon Pharmaceuticals Inc (XENE) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Xenon Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Xenon Pharmaceuticals Inc share’s latest price of $36.68 as on September 18, 2025 at 1:29 am IST, you will get 0.2726 shares of Xenon Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Xenon Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Xenon Pharmaceuticals Inc stock has given 211.71% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?